LSTM Home > LSTM Research > LSTM Online Archive

Factors influencing mass drug administration adherence and community drug distributor opportunity costs in Liberia: A mixed-methods approach

Agboraw, Efundem, Sosu, Fred, Dean, Laura ORCID: https://orcid.org/0000-0002-4910-9707, Siakeh, Alice, Thomson, Rachael, Kollie, Karsor and Worrall, Eve ORCID: https://orcid.org/0000-0001-9147-3388 (2021) 'Factors influencing mass drug administration adherence and community drug distributor opportunity costs in Liberia: A mixed-methods approach'. Parasites & Vectors, Vol 14, Issue 557.

[img]
Preview
Text
s13071-021-05058-w.pdf - Published Version
Available under License Creative Commons Attribution.

Download (911kB) | Preview

Abstract

Background
Preventive chemotherapy delivered via mass drug administration (MDA) is essential for the control of neglected tropical diseases (NTDs), including lymphatic filariasis (LF), schistosomiasis and onchocerciasis. Successful MDA relies heavily on community drug distributor (CDD) volunteers as the interface between households and the health system. This study sought to document and analyse demand-side (households) and supply-side (health system) factors that affect MDA delivery in Liberia.

Methods
Working in two purposively selected counties, we conducted a household MDA access and adherence survey; a CDD survey to obtain information on direct and opportunity costs associated with MDA work; an observational survey of CDDs; and key informant surveys (KIS) with community-level health workers. Data from the CDD survey and Liberian minimum wage rates were used to calculate the opportunity cost of CDD participation per MDA round. The observational data were used to calculate the time spent on individual household-level tasks and CDD time costs per house visited. KIS data on the organisation and management of the MDA in the communities, and researcher reflections of open-ended survey responses were thematically analysed to identify key demand- and supply-side challenges.

Results
More respondents were aware of MDA than NTD in both counties. In Bong, 39% (103/261) of respondents reported taking the MDA tablet in the last round, with “not being informed” as the most important reason for non-adherence. In Maryland, 56% (147/263) reported taking MDA with “being absent” at the time of distribution being important for non-adherence. The mean cost per CDD of participating in the MDA round was −$11.90 (median $5.04, range −$169.62 to $30.00), and the mean time per household visited was 17.14 min which equates to a mean opportunity cost of $0.03 to $0.05 per household visited. Thematic analysis identified challenges, including shortages of and delays in medicine availability; CDD frustration over costs; reporting challenges; and household concerns about drug side effects.

Conclusions
Improved adherence to MDA and subsequent elimination of NTDs in Liberia would be supported by an improved medicine supply chain, financial compensation for CDDs, improved training, healthcare workforce strengthening, greater community involvement, capacity building, and community awareness.

Item Type: Article
Subjects: WA Public Health > Preventive Medicine > WA 108 Preventive health services. Preventive medicine. Travel Medicine.
WA Public Health > Health Problems of Special Population Groups > WA 395 Health in developing countries
WC Communicable Diseases > Tropical and Parasitic Diseases > WC 680 Tropical diseases (General)
Faculty: Department: Biological Sciences > Vector Biology Department
Biological Sciences > Department of Tropical Disease Biology
Clinical Sciences & International Health > International Public Health Department
Digital Object Identifer (DOI): https://doi.org/10.1186/s13071-021-05058-w
Depositing User: Kelly Smyth
Date Deposited: 03 Nov 2021 17:50
Last Modified: 03 Nov 2021 17:50
URI: https://archive.lstmed.ac.uk/id/eprint/19127

Statistics

View details

Actions (login required)

Edit Item Edit Item